In a highly contested online race, a charity organization in Nigeria, the Child’s Right and Rehabilitation Network (CRARN) has won the 2022 international Freedom Prize in Normandy, France.
The Call for Chapters (CFC) for the IGI Global book entitled “Exploring the Efficacy and Beneficence of Complementary and Alternative Medicinal Products in Disease Therapy:” https://www.igi-global.com/publish/call-for-papers/call-details/4155 has been revised to include elements of epidemiology and public health in an effort to expand book chapter contribution and readership.
Manuscripts on infectious diseases with a focus on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2 [COVID-19]) are welcome! Articles that discuss disease onset with an emphasis on symptomatology, distribution and progression utilizing complementary and alternative medicinal products as defense strategies in achieving disease tolerance and resistance shall ignite the curiosity of the scientific community and a broad spectrum of readers.
As the United States and countries across the globe recover from the scourge and ravages of COVID-19, scientists, healthcare professionals and other stakeholders proffer mitigative models that aspire to contain and constrain the pandemic.
In the mad race to the coveted price of an antibody and/or vaccine, drugs such as remdesivir, hydrochloroquine etc., have achieved instant but singular notoriety. As the pharmaceutical industry undertakes clinical trials and makes pharmacokinetic and pharmacodynamic determinations on certain drugs of particular interest, it once again presents an opportunity for discussions on the place of complementary and alternative medicinal products in the treatment of acute and chronic disorders.
To accommodate proposals that may fit this, and other narratives, the editor requested for and secured from the publisher, an extension of the schedule of deadlines for the SEEED-IGI Global book entitled “Exploring the Efficacy and Beneficence of Complementary and Alternative Medicinal Products in Disease Therapy.” Consequently, the editorial advisory board (EAB) renews its call for book chapter contributions that are apropos: https://www.igi-global.com/publish/call-for-papers/call-details/4155.
A preliminary look at data from hospitalized adults diagnosed with #COVID19 in a randomized, controlled clinical trial to evaluate the safety and efficacy of the investigational antiviral remdesivir is showing promising results. https://t.co/QBIw99oZtrpic.twitter.com/7BeqCV0oDO
Team SEEED wishes its partners, vendors, employees, candidate respondents, their family members and the entirety of Christendom, a life filled with happiness and the incontrovertible joy of GOD.
May we experience happiness and joy as we celebrate Christmas! May we receive gladness and good tidings as we usher in the New Year!
The send out of questionnaires (Q1-6) for the book entitled “Evaluation of Economic Progression Across Middle-income Americans: Narratives and Research Perspectives (EEPAMANRP)” is on-going.
The authors encourage candidate respondents to complete each survey when received.
The expeditious completion of surveys shall enable us meet the schedule of deadlines determined by the publisher.
Please direct all inquires to the authors, Eshiet ER and Moore D, + 713-747-7477.
Call for Chapters (CFC) for the book entitled “Exploring the Efficacy and Beneficence of Complementary and Alternative Medicinal Products in Disease Therapy” has been extended.